The article presents the current application of corneal collagen crosslinking. The original indication of riboflavin – Ultraviolet-A (UVA) induced corneal collagen cross-linking is to arrest the progression of keratoconus. Studies show that it is effective in arresting the progression of keratoconus and post-LASIK ectasia with the standard Dresden protocol (epithelium-off ). There are also improvements in visual, keratometric and topographic measurements over time. Severe complications of cross-linking are rare. The epithelium-on techniques have less efficacy than the Dresden protocol. Accelerated protocols have variable results, with some studies reporting comparable outcomes to the Dresden protocol while other studies reporting less efficacious outcomes. Cross- linking combined with refractive procedures provide better visual outcome but long term studies are warranted. Cross-linking for the treatment of infective keratitis is a promising new treatment modality. Initial studies show that it is more effective for superficial rather than deep infections and for bacterial rather than fungal infections. Conclusions: Corneal cross-linking is a procedure with an expanding list of indications from the treatment of corneal ectasias to infective keratitis. While the standard Dresden protocol is established as the gold standard treatment for progressive keratoconus, the more recent protocols may require further refinements, investigative and long-term studies.
Cornea collagen cross-linking, post-LASIK ectasia, keratoconus, infective keratitis
1. Wollensak G., Spoerl E., Seiler T. Ribo'avin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5): 620-7. doihttps://doi.org/10.1016/S0002-9394(02)02220-1.
2. O’Brart D. P, Chan E., Samaras K., Patel P., Shah S. P. A randomised, prospective study to investigate the e쫀cacy of ribo'avin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol. 2011;95(11):1519-24. doihttps://doi.org/10.1136/bjo.2010.196493.
3. Wittig-Silva C., Chan E., Islam F. M., Wu T., Whiting M., Snibson G. R. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: Three-year results. Ophthalmology. 2014;121(4): 812-21. doihttps://doi.org/10.1016/j.ophtha.2013.10.028.
4. Seiler T., Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006; 25(9): 1057-9. doihttps://doi.org/10.1097/01.ico.0000225720.38748.58.
5. Kanellopoulos A. J., Asimellis G. Introduction of quantitative and qualitative cornea optical coherence tomography findings induced by collagen cross-linking for keratoconus: A novel e㐴ect measurement benchmark. Clin Ophthalmol. 2013;7:329-35. doihttps://doi.org/10.2147/OPTH.S40455.
6. Coskunseven E., Jankov M. R. II, Hafezi F. Contralateral eye study of corneal collagen cross-linking with ribo'avin and UVA irradiation in patients with keratoconus. J Refract Surg. 2009;25(4):371-6. doi:10.3928/ 1081597X-20090401-02.
7. O’Brart D. P., Kwong T. Q., Patel P., McDonald R. J., O’Brart N. A. Long-term follow-up of ribo'avin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus. Br J Ophthalmol. 2013;97(4):433-7. doihttps://doi.org/10.1136/bjophthalmol-2012-302556.
8. Hersh P. S., Greenstein S. A., Fry K. L. Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg. 2011;37(1):149-60. doihttps://doi.org/10.1016/j.jcrs.2010.07.030.
9. Richoz O., Mavrakanas N., Pajic B., Hafezi F. Corneal collagen cross-linking for ectasia aer LASIK and photorefractive keratectomy: Longterm results. Ophthalmology. 2013;120(7):1354-9. doihttps://doi.org/10.1016/j.ophtha.2012.12.027.
10. Chatzis N., Hafezi F. Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012;28(11):753-8. doihttps://doi.org/10.3928/1081597X-20121011-01.
11. Arora R., Gupta D., Goyal J. L., Jain P. Results of corneal collagen cross-linking in pediatric patients. J Refract Surg. 2012;28(11):759-62. doihttps://doi.org/10.3928/1081597X-20121011-02.
12. Buzzonetti L., Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results. J Refract Surg. 2012;28(11):763-7. doihttps://doi.org/10.3928/1081597X-20121011-03.
13. Magli A., Forte R., Tortori A., Capasso L., Marsico G., Piozzi E. Epithelium-o㐴 corneal collagen cross-linking versus transepithelial crosslinking for pediatric keratoconus. Cornea. 2013;32(5):597-601. doihttps://doi.org/10.1097/ICO.0b013e31826cf32d.
14. Caporossi A., Mazzotta C., Paradiso A. L., Baiocchi S., Marigliani D., Caporossi T. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg. 2013;39(8):1157-63. doihttps://doi.org/10.1016/j.jcrs.2013.03.026.
15. Bunsen R. H. Photochemische Untersuchungen PoggendorǦ’s Annalen. 1855; 96: 373-94.
16. Wernli J., Schumacher S., Spoerl E., Mrochen M. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54(2):1176-80. doihttps://doi.org/10.1167/iovs.12-11409.
17. Kanellopoulos A. J. Long term results of a prospective randomized bilateral eye comparison trial of higher ǟuence, shorter duration ultraviolet A radiation, and riboflavin collagen cross linking for progressive keratoconus. Clin Ophthalmol. 2012;6:97-101. doihttps://doi.org/10.2147/OPTH.S27170.
18. Gatzioufas Z., Richoz O., Brugnoli E., Hafezi F. Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg. 2013;29(12):846-8. doihttps://doi.org/10.3928/1081597X-20131023-03.
19. Tomita M., Mita M., Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg. 2014;40(6):1013-20. doihttps://doi.org/10.1016/j.jcrs.2013.12.012.
20. Kymionis G. D., Tsoulnaras K. I., Grentzelos M. A., Liakopoulos D. A., Tsakalis N. G., Blazaki S. V. Evaluation of corneal stromal demarcation line depth following standard and a modiđed-accelerated collagen cross-linking protocol. Am J Ophthalmol. 2014;158(4):671-5.doihttps://doi.org/10.1016/j.ajo.2014.07.005.
21. Shetty R., Pahuja N. K., Nuijts R. M. Current protocols of corneal collagen cross-linking: Visual, refractive, and tomographic outcomes. Am J Ophthalmol. 2015;160(2):243-9. doihttps://doi.org/10.1016/j.ajo.2015.05.019.
22. Mazzotta C., Traversi C., Paradiso A. L., Latronico M. E., Rechichi M. Pulsed light accelerated crosslinking versus continuous light accelerated crosslinking: One-Year results. J Ophthalmol. 2014;014:604731. doihttps://doi.org/10.1155/2014/604731.
23. Kanellopoulos A. J., Binder P. S. Collagen Cross-Linking (CCL) with sequential topography-guided PRK: A temporizing alternative for keratoconus to penetrating keratoplasty. Cornea. 2007;26(7):891-5. doihttps://doi.org/10.1097/ICO.0b013e318074e424.
24. Kanellopoulos A. J. Comparison of sequential vs same-day simultaneous collagen cross-linking and topography-guided PRK for treatment of keratoconus. J Refract Surg. 2009;25(9):S812-8. doi:10.3928/ 1081597X-20090813-10.
25. Krueger R. R., Kanellopoulos A. J. Stability of simultaneous topography-guided photorefractive keratectomy and riboflavin/UVA cross-linking for progressive keratoconus: Case reports. J Refract Surg. 2010;26(10):S827-32. doihttps://doi.org/10.3928/1081597X-20100921-11.
26. Kymionis G. D., Grentzelos M. A., Kounis G. A., Diakonis V. F., Limnopoulou A. N., Panagopoulou S. I. Combined transepithelial phototherapeutic keratectomy and corneal collagen cross-linking for progressive keratoconus. Ophthalmology. 2012;119(9):1777-84. doihttps://doi.org/10.1016/j.ophtha.2012.03.038.
27. Chan C. C., Sharma M., Wachler B. S. EǦect of inferior-segment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg. 2007;33(1):75-80. doihttps://doi.org/10.1016/j.jcrs.2006.09.012.
28. Coskunseven E., Jankov M. R. II, Hafezi F., Atun S., Arslan E., Kymionis G. D. EǦect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus. J Cataract Refract Surg. 2009;35(12):2084-91. doihttps://doi.org/10.1016/j.jcrs.2009.07.008.
29. El Awady H., Shawky M., Ghanem A. A. Evaluation of collagen crosslinking in keratoconus eyes with Kera intracorneal ring implantation. Eur J Ophthalmol. 2012; 22(Suppl. 7): S62-8. doihttps://doi.org/10.5301/ejo.5000020.
30. Fadlallah A., Dirani A., El Rami H., Cherfane G., Jarade E. Safety and visual outcome of Visian toric ICL implantation a3er corneal collagen cross-linking in keratoconus. J Refract Surg. 2013;29(2):84-9. doi:103928/1081597X-20130117-01.
31. G'ell J. L., Morral M., Malecaze F., Gris O., Elies D., Manero F. Collagen crosslinking and toric iris-claw phakic intraocular lens for myopic astigmatism in progressive mild to moderate keratoconus. J Cataract Refract Surg. 2012;38(3):475-84. doihttps://doi.org/10.1016/j.jcrs.2011.10.031.
32. Kanellopoulos A. J., Dupps W. J., Seven I., Asimellis G. Toric topographically customized transepithelial, pulsed, very high-fluence, higher energy and higher riboǟavin concentration collagen cross-linking in keratoconus. Case Rep Ophthalmol. 2014;5(2):172-80. doihttps://doi.org/10.1159/000363371.
33. Sinha Roy A., Dupps W. J. Jr. Patient-speciđc computational modeling of keratoconus progression and differential responses to collagen crosslinking. Invest Ophthalmol Vis Sci. 2011; 52(12): 9174-87. doihttps://doi.org/10.1167/iovs.11-7395.
34. Kanellopoulos A. J. Novel myopic refractive correction with transepithelial very high-fluence collagen cross-linking applied in a customized pattern: early clinical results of a feasibility study. Clin Ophthalmol. 2014;8:697-702. doihttps://doi.org/10.2147/OPTH.S59934.
35. Lim W. K., Soh Z. D., Choi H. K. Y., ǽeng J. T. S. Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin 1053 № ,32 mot ,0202TAVRIChESKIY MEDIKO-BIOLOGIChESKIY VESTNIKOphthalmol. 2017;11:1205-11. doihttps://doi.org/10.2147/OPTH.S137712.
36. Kanellopoulos A. J., Asimellis G. Hyperopic correction: Clinical validation with epithelium-on and epithelium-oǦ protocols, using variable ǟuence and topographically customized collagen corneal crosslinking. Clin Ophthalmol. 2014;8:2425-33. doihttps://doi.org/10.2147/OPTH.S68222.
37. Chen Y. I., Chien K. L., Wang I. J. An interval-censored model for predicting myopic regression a3er laser in situ keratomileusis. Invest Ophthalmol Vis Sci. 2007;48(8):3516-23. doihttps://doi.org/10.1167/iovs.06-1044.
38. Kanellopoulos A. J., Asimellis G., Karabatsas C. Comparison of prophylactic higher ǟuence corneal cross-linking to control, in myopic LASIK, one year results. Clin Ophthalmol. 2014;8:2373-81. doihttps://doi.org/10.2147/OPTH.S68372.
39. Kanellopoulos A. J., Asimellis G. Combined laser in situ keratomileusis and prophylactic high-ǟuence corneal collagen crosslinking for high myopia: two-year safety and ecacy. J Cataract Refract Surg. 2015;41(7):1426-33. doihttps://doi.org/10.1016/j.jcrs.2014.10.045.
40. Kanellopoulos A. J., Kahn J. Topography-guided hyperopic LASIK with and without high irradiance collagen cross-linking: initial comparative clinical findings in a contralateral eye study of 34 consecutive patients. J Refract Surg. 2012;28(11):837-40. doihttps://doi.org/10.3928/1081597X-20121005-05.
41. Kanellopoulos A. J., Asimellis G. Epithelial remodeling after femtosecond laser-assisted high myopic LASIK: comparison of stand-alone with LASIK combined with prophylactic high-fluence cross-linking. Cornea. 2014;33(5):463-9. doihttps://doi.org/10.1097/ICO.0000000000000087.
42. Tomita M. Combined laser in-situ keratomileusis and accelerated corneal cross-linking: an update. Curr Opin Ophthalmol. 2016;27(4):304-10. doihttps://doi.org/10.1097/ICU.0000000000000281.
43. Spoerl E., Wollensak G., Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35-40. doihttps://doi.org/10.1080/02713680490513182.
44. Arboleda A., Miller D., Cabot F., Taneja M., Aguilar M. C., Alawa K. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates Am J Ophthalmol. 2014;158(1):64-70. doihttps://doi.org/10.1016/j.ajo.2014.04.007.
45. Iseli H. P., ǽiel M. A., Hafezi F., Kampmeier J., Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590-4. doi:10.1097/ ICO.0b013e318169d698.
46. Makdoumi K., Mortensen J., Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea. 2010;29(12):1353-8. doihttps://doi.org/10.1097/ICO.0b013e3181d2de91.
47. Price M. O., Tenkman L. R., Schrier A., Fairchild K. M., Trokel S. L., Price F. W. Jr. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg. 2012;28(10):706-13. doihttps://doi.org/10.3928/1081597X-20120921-06.
48. Makdoumi K., Mortensen J., Sorkhabi O., Malmvall B. E., Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: A pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):95-102. doi:10.1007/ s00417-011-1754-1.
49. Said D. G., Elalfy M. S., Gatzioufas Z. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377-82. doihttps://doi.org/10.1016/j.ophtha.2014.01.011.
50. Uddaraju M., Mascarenhas J., Das M. R., Radhakrishnan N., Keenan J. D., Prajna L. Corneal Cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: A randomized trial. Am J Ophthalmol. 2015;160(1):131-4 e5. doihttps://doi.org/10.1016/j.ajo.2015.03.024.
51. Spadea L. Corneal collagen cross-linking with riboǟavin and UVA irradiation in pellucid marginal degeneration. J Refract Surg. 2010;26(5):375-7. doihttps://doi.org/10.3928/1081597X-20100114-03.
52. Kymionis G. D., Karavitaki A. E., Kounis G. A., Portaliou D. M., Yoo S. H., Pallikaris I. G. Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking. J Cataract Refract Surg. 2009;35(7):1298-301. doihttps://doi.org/10.1016/j.jcrs.2009.03.025.
53. Sharma N., Roy S., Maharana P. K. Outcomes of corneal collagen crosslinking in pseudophakic bullous keratopathy. Cornea. 2014;33(3):243-6. doihttps://doi.org/10.1097/ICO.0000000000000004.
54. Kozobolis V., Labiris G., Gkika M. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea. 2010;29(2):235-8. doihttps://doi.org/10.1097/ICO.0b013e3181a81802.
55. Mukherjee A., Hayes S., Aslanides I., Lanchares E., Meek K. M. Donor cross-linking for keratoplasty: a laboratory evaluation. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2223-8. doihttps://doi.org/10.1007/s00417-015-3160-6.
56. Huang T., Ye R., Ouyang C., Hou C., Hu Y., Wu Q. Use of donors predisposed by corneal collagen cross-linking in penetrating keratoplasty for treating patients with keratoconus. Am J Ophthalmol. 2017;184:115-20. doihttps://doi.org/10.1016/j.ajo.2017.10.003.
57. Robert M. C., Arafat S. N., Ciolino J. B. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens. 2014;40(6):376-81. doihttps://doi.org/10.1097/ICL. 0000000000000081.
58. Randleman J. K. R. Corneal collagen cross-linking complications and their management Corneal Collagen Cross Linking. ǽorofare, NJ: SLACK; 2013: 89-96.
59. Shetty R., Kaweri L., Nuijts R. M., Nagaraja H., Arora V., Kumar R. S. Prođle of microbial keratitis a3er corneal collagen cross-linking. BioMed Res Int. 2014:340509. doihttps://doi.org/10.1155/2014/340509.
60. Sharma A., Nottage J. M., Mirchia K., Sharma R., Mohan K., Nirankari V. S. Persistent corneal edema a3er collagen cross-linking for keratoconus Am J Ophthalmol. 2012;154(6):922-6. doihttps://doi.org/10.1016/j.ajo.2012.06.005
